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A 57-year-old  woman,  with  a  history  of  recurrent  deep  venous  thromboses,  was  admitted
for  progressive  dyspnoea  rapidly  improved  by  diuretic  treatment;  her  electrocardiogram
showed  deeply  inverted  T-waves  in  precordial  leads.  Pulmonary  embolism  was  dismissed  by
a  normal  lung  scan.  Early  coronary  angiography  was  completely  normal.  However,  echocar-
diography  revealed  a  bilobulated  mass  attached  to  the  apex  of  an  apparently  normally
contracting  LV,  compatible  with  mural  thrombus  (Fig.  1A;  Video  1),  prompting  heparin
therapy.
CMR  examination  performed  2  weeks  later  demonstrated  a  small  apical  area  of  subendo-
cardial  delayed  contrast  enhancement,  characteristic  of  ischaemic  injury,  with  resolution
of  the  previously  described  mass  (Fig.  1B)  and  no  obvious  LV  wall  motion  abnormalities
(Videos  2  and  3).
Laboratory  tests  were  remarkable  for  positive  immunoglobulin  G  and  M  anticardiolipin
antibodies.  Primary  APS  was  diagnosed  as  no  other  underlying  disease  could  be  identiﬁed,
the  anticardiolipin  antibodies  remaining  elevated  13  weeks  later.
Our  ﬁndings  suggest  that  myocardial  ischaemia  in  this  patient  was  caused  by  thromboticMicrovasculopathie
cardiaque
cardiac  microvasculopathy.  Eventually,  the  ischaemically  injured  overlying  endocardium
would  act  as  a  trigger  for  clot  formation.  However,  mural  thrombosis  into  a  normally
contracting  LV  remains  most  unusual.  We  therefore  believe  that  systemic  APS-related
coagulopathy  played  a  substantial  role  in  both  events.
Abbreviations: APS, Antiphospholipid syndrome; CMR, Cardiac magnetic resonance; LV, Left ventricle.
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Figure 1. A. Transthoracic echocardiography shows a bi-lobulated mass attached to the apex of the left ventricle. B. Cardiovascular
m hamber left ventricle view acquisition with phase-sensitive detection
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Supplementary  data  associated  with  this  arti-
cle  can  be  found,  in  the  online  version,  at
doi:10.1016/j.acvd.2011.05.014.agnetic resonance: inversion recovery delayed-enhanced four-c
emonstrates the resolution of the intracardiac mass after anticoag
n the related left ventricle apex.
This  case  points  toward  a  possible  pathogenic  mechanism
or  intracardiac  thrombosis  in  APS,  illustrating  the  subtle
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